title: Clinical effect of Fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage.
authors.affiliation: Department of Neurosurgery, National Disaster Medical Center, Tokyo, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Masaoka
authors.forename: Y
authors.initials: Y
authors.lastname: Takasato
authors.forename: T
authors.initials: T
authors.lastname: Nojiri
authors.forename: T
authors.initials: T
authors.lastname: Hayakawa
authors.forename: H
authors.initials: H
authors.lastname: Akimoto
authors.forename: H
authors.initials: H
authors.lastname: Yatsushige
authors.forename: H
authors.initials: H
authors.lastname: Toumori
authors.forename: Y
authors.initials: Y
authors.lastname: Miyazaki
authors.forename: M
authors.initials: M
authors.lastname: Honma
mesh_terms: D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002533:Cerebral Angiography; D005260:Female; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000627:therapeutic use*; D020301:Vasospasm, Intracranial / Q000000981:diagnostic imaging / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D014665:Vasodilator Agents; D019307:1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; C049347:fasudil